Epidemiology of HCV infection in the Central European region

Opinion leaders in each of four countries in the Central European region summarize the available data on hepatitis C virus (HCV) epidemiology. The overall prevalence of anti-HCV antibody reactivity in this region varies between 0.2% and 2.1%, the most prevalent HCV genotype is GT 1. The commonest ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbánek, Petr, Kristian, Pavol, Makara, Michael, Hunyady, Bela, Tomasiewicz, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497410/
https://www.ncbi.nlm.nih.gov/pubmed/28856264
http://dx.doi.org/10.5114/ceh.2016.58849
_version_ 1783248153998262272
author Urbánek, Petr
Kristian, Pavol
Makara, Michael
Hunyady, Bela
Tomasiewicz, Krzysztof
author_facet Urbánek, Petr
Kristian, Pavol
Makara, Michael
Hunyady, Bela
Tomasiewicz, Krzysztof
author_sort Urbánek, Petr
collection PubMed
description Opinion leaders in each of four countries in the Central European region summarize the available data on hepatitis C virus (HCV) epidemiology. The overall prevalence of anti-HCV antibody reactivity in this region varies between 0.2% and 2.1%, the most prevalent HCV genotype is GT 1. The commonest route of transmission is intravenous drug abuse at present.
format Online
Article
Text
id pubmed-5497410
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-54974102017-08-30 Epidemiology of HCV infection in the Central European region Urbánek, Petr Kristian, Pavol Makara, Michael Hunyady, Bela Tomasiewicz, Krzysztof Clin Exp Hepatol Review Paper Opinion leaders in each of four countries in the Central European region summarize the available data on hepatitis C virus (HCV) epidemiology. The overall prevalence of anti-HCV antibody reactivity in this region varies between 0.2% and 2.1%, the most prevalent HCV genotype is GT 1. The commonest route of transmission is intravenous drug abuse at present. Termedia Publishing House 2016-03-24 2016-03 /pmc/articles/PMC5497410/ /pubmed/28856264 http://dx.doi.org/10.5114/ceh.2016.58849 Text en Copyright: © 2016 Clinical and Experimental Hepatology http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Review Paper
Urbánek, Petr
Kristian, Pavol
Makara, Michael
Hunyady, Bela
Tomasiewicz, Krzysztof
Epidemiology of HCV infection in the Central European region
title Epidemiology of HCV infection in the Central European region
title_full Epidemiology of HCV infection in the Central European region
title_fullStr Epidemiology of HCV infection in the Central European region
title_full_unstemmed Epidemiology of HCV infection in the Central European region
title_short Epidemiology of HCV infection in the Central European region
title_sort epidemiology of hcv infection in the central european region
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497410/
https://www.ncbi.nlm.nih.gov/pubmed/28856264
http://dx.doi.org/10.5114/ceh.2016.58849
work_keys_str_mv AT urbanekpetr epidemiologyofhcvinfectioninthecentraleuropeanregion
AT kristianpavol epidemiologyofhcvinfectioninthecentraleuropeanregion
AT makaramichael epidemiologyofhcvinfectioninthecentraleuropeanregion
AT hunyadybela epidemiologyofhcvinfectioninthecentraleuropeanregion
AT tomasiewiczkrzysztof epidemiologyofhcvinfectioninthecentraleuropeanregion

Ejemplares similares